Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened using a low dose CT scan.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Current diagnosis of lung cancer with a driver mutation.

• Known driver mutation (e.g. via NGS, PCR, IHC, FISH, RT-PCR etc.)

• Able and willing to give informed consent.

• Able and willing to complete the screening questionnaire.

⁃ Cohort A:

• Age 40 - 80.

• Must have a first degree relative (mother, father, sibling, biological child) eligible for Cohort A. Note: Multiple first degree relatives of a Cohort A eligible participant may be approached for participation into the trial.

• Smoked \< 20 pack years; a. Pack years = numbers of packs per day × number of years smoked; b. One pack year is the equivalent of smoking an average of 20 cigarettes (1 pack) per day for a year.

• Be able to undergo a low dose chest CT scan.

• If an upper respiratory infection (pneumonia, COVID19, flu, etc.) occurred in the last 3 months, this infection must have resolved by time of enrollment.

• Able and willing to provide informed consent.

• Able and willing to comply with the protocol requirements

⁃ Cohort B:

Locations
United States
California
Chao Family Comprehensive Cancer Center University of California, Irvine
RECRUITING
Orange
Contact Information
Primary
Chao Family Comprehensive Cancer Center University of California, Irvine
ucstudy@uci.edu
1-877-827-8839
Backup
University of California Irvine Medical
Time Frame
Start Date: 2025-05-08
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 1753
Treatments
Experimental: Low Dose CT Scan of First Degree Relatives of Lung Cancer Patients
First degree relatives of patients with lung cancer with a known driver mutation will receive a low dose CT scan of the chest to screen for lung abnormality.
Related Therapeutic Areas
Sponsors
Leads: University of California, Irvine

This content was sourced from clinicaltrials.gov